Three HZI scientists among the world's most cited researchers

Hinweis zur Verwendung von Bildmaterial: Die Verwendung des Bildmaterials zur Pressemitteilung ist bei Nennung der Quelle vergütungsfrei gestattet. Das Bildmaterial darf nur in Zusammenhang mit dem Inhalt dieser Pressemitteilung verwendet werden. Falls Sie das Bild in höherer Auflösung benötigen oder Rückfragen zur Weiterverwendung haben, wenden Sie sich bitte direkt an die Pressestelle, die es veröffentlicht hat.

Highly cited researchers from the HZI: Andreas Keller, Josef Penninger and Marc Stadler. | Quelle: Oliver Dietze, Verena Meier | Copyright: HIPS/Oliver Dietze; HZI/Verena Meier | Download

Every year, the company Clarivate Analytics publishes a list of "Highly Cited Researchers" and honors scientists who have made a particularly significant impact on their fields. In 2024, researchers from the Helmholtz Centre for Infection Research (HZI) are once again among them: This time, bioinformatician Prof. Andreas Keller, Scientific Director of the HZI and geneticist Prof. Josef Penninger and biotechnologist Prof. Marc Stadler were honored for their scientific publications.

Prof. Andreas Keller heads the department “Clinical Bioinformatics” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the HZI in cooperation with Saarland University. He uses computational methods to investigate how bacteria, as producers of natural products, interact with humans and how they can trigger diseases or even protect against them. A special focus of the research is on the regulatory mechanisms of non-coding RNAs.

The Scientific Director of the HZI, Prof. Josef Penninger, heads the newly established "Innovative Organoid Research" department. Together with his team, he investigates the genetic causes of diseases and uses organoids, i.e. miniature organs grown in cell culture, among other things. Organoids can also be used to study infections in detail, carry out vaccine tests and develop innovative therapeutic approaches.

Prof. Marc Stadler's department “Microbial Drugs” searches for antibiotically active natural substances in fungi and soil bacteria. Due to the increasing spread of antibiotic resistance among dangerous pathogens, current drugs are increasingly losing their effectiveness, meaning that new drug candidates are urgently needed. Stadler also develops analytical methods for the search and structural elucidation of secondary substances and establishes their production processes on a pre-industrial scale.

This year’s list of “Highly-cited researchers” comprises of 6886 researchers.

This press release is also available on our website: https://www.helmholtz-hzi.de/en/media-center/newsroom/news-detail/three-hzi-scientists-among-the-worlds-most-cited-researchers/.

Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and its other sites in Germany are engaged in the study of bacterial and viral infections and the body’s defence mechanisms. They have a profound expertise in natural compound research and its exploitation as a valuable source for novel anti-infectives. As member of the Helmholtz Association and the German Center for Infection Research (DZIF) the HZI performs translational research laying the ground for the development of new treatments and vaccines against infectious diseases. www.helmholtz-hzi.de/en

Contact:
Susanne Thiele, Spokesperson
susanne.thiele@helmholtz-hzi.de
Dr Andreas Fischer, Editor
andreas.fischer@helmholtz-hzi.de

Helmholtz Centre for Infection Research
Press and Communications
Inhoffenstr. 7
D-38124 Braunschweig
Germany
Phone: +49 531 6181-1400; -1405

Weitere Informationen:
https://clarivate.com/highly-cited-researchers/